(Q39474369)

English

Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin

scientific article published on July 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin (English)

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Bacteroides fragilis

object named as

Bacteroides fragilis

1 reference

based on heuristic

inferred from title

author name string

R Bachoual

1

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

L Dubreuil

2

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

C J Soussy

3

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

J Tankovic

4

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

language of work or name

0 references

publication date

1 July 2000

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

44

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

7

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

1842-1845

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

Molecular cloning of the gyrA and gyrB genes of Bacteroides fragilis encoding DNA gyrase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89971

12 September 2017

Comparative in vitro activities of trovafloxacin (CP-99,219) against 221 aerobic and 217 anaerobic bacteria isolated from patients with intra-abdominal infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89971

12 September 2017

Active efflux of norfloxacin by Bacteroides fragilis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89971

14 September 2017

Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89971

14 September 2017

Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89971

14 September 2017

The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89971

14 September 2017

Wound and intraabdominal infections: microbiological considerations and approaches to treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89971

25 September 2017

Susceptibility of 497 clinical isolates of gram-negative anaerobes to trovafloxacin and eight other antibiotics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89971

21 August 2018

Treatment of acute gynecologic infections with trovafloxacin. Trovafloxacin Surgical Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89971

21 August 2018

Attributable mortality of bacteremia associated with the Bacteroides fragilis group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10858340

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial therapy for surgical prophylaxis and for intra-abdominal and gynecologic infections

1 reference

https://pubmed.ncbi.nlm.nih.gov/10858340

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/10858340

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of fluoroquinolone resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/10858340

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.44.7.1842-1845.2000

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

release_3p3334c7hjcirl7ydcwhglefbe

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39474369&oldid=1829992937"